 PHILADELPHIA, Jan. 04, 2022 GLOBE NEWSWIRE -- Century Therapeutics NASDAQ: IPSC, an innovative biotechnology company developing induced pluripotent stem cell iPSC-derived cell therapies in immuno-oncology, today announced that Lalo Flores, Ph.D., Chief Executive Officer, will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022 at 1:30 PM ET. 